AR010031A1 - Vacuna oral para animales - Google Patents
Vacuna oral para animalesInfo
- Publication number
- AR010031A1 AR010031A1 ARP970104941A ARP970104941A AR010031A1 AR 010031 A1 AR010031 A1 AR 010031A1 AR P970104941 A ARP970104941 A AR P970104941A AR P970104941 A ARP970104941 A AR P970104941A AR 010031 A1 AR010031 A1 AR 010031A1
- Authority
- AR
- Argentina
- Prior art keywords
- animals
- oral vaccine
- vaccine
- younger
- pathogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2880296P | 1996-10-28 | 1996-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR010031A1 true AR010031A1 (es) | 2000-05-17 |
Family
ID=21845518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970104941A AR010031A1 (es) | 1996-10-28 | 1997-10-24 | Vacuna oral para animales |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR010031A1 (fr) |
AU (1) | AU4133397A (fr) |
WO (1) | WO1998018453A1 (fr) |
ZA (1) | ZA979592B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL148247A0 (en) * | 1999-08-24 | 2002-09-12 | Teva Pharma | A vaccine composition and method of using the same |
US6592869B2 (en) * | 1999-08-24 | 2003-07-15 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
US7790178B2 (en) | 2002-12-19 | 2010-09-07 | Intervet International B.V. | Trivalent vaccine with maternal anitbody transfer via the milk |
NZ577855A (en) * | 2006-12-27 | 2012-07-27 | Pfizer Prod Inc | Vaccination schedule to prevent canine disease |
WO2011008958A1 (fr) * | 2009-07-17 | 2011-01-20 | The Board Of Regents For Oklahoma State University | Vaccins supralinguaux et applicateurs supralinguaux |
MX364946B (es) * | 2012-04-04 | 2019-05-15 | Vaxform Llc | Sistema adyuvante mejorado para la administración de vacunas orales. |
AR097762A1 (es) * | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
KR102396817B1 (ko) * | 2014-02-20 | 2022-05-11 | 박사르트, 인크. | 소장 전달을 위한 제형들 |
EP3137633A4 (fr) * | 2014-04-28 | 2017-11-29 | Sigma-Aldrich Co. LLC | Modification épigénétique de génomes de mammifères à l'aide d'endonucléases ciblées |
EP3791859A1 (fr) | 2015-06-12 | 2021-03-17 | Vaxart, Inc. | Formulations pour l'administration dans l'intestin grêle d'antigènes du rsv et des norovirus |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152413A (en) * | 1978-08-18 | 1979-05-01 | Chromalloy American Corporation | Oral vaccine for swine dysentery and method of use |
AU576907B2 (en) * | 1984-11-01 | 1988-09-08 | American Home Products Corporation | Oral vaccines comprising live recombinant adenoviruses |
US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
RU2045960C1 (ru) * | 1992-07-01 | 1995-10-20 | Соболева Галина Леонидовна | Вакцина для профилактики чумы, инфекционного гепатита, аденовироза, парвовирусного энтерита и лептоспироза собак |
-
1997
- 1997-09-22 AU AU41333/97A patent/AU4133397A/en not_active Abandoned
- 1997-09-22 WO PCT/IB1997/001136 patent/WO1998018453A1/fr active Application Filing
- 1997-10-24 AR ARP970104941A patent/AR010031A1/es unknown
- 1997-10-27 ZA ZA979592A patent/ZA979592B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU4133397A (en) | 1998-05-22 |
WO1998018453A1 (fr) | 1998-05-07 |
ZA979592B (en) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991524L (no) | Vaksiner | |
PT90727A (pt) | Processo para a preparacao de uma proteina possuindo um ou mais determinantes imuno-reactivos e/ou antigenicos de um antigenio de superficie eimeria e de vacinas contra a coccidiose que a contem | |
ES2140076T3 (es) | Vacunas que contienen una saponina y un esterol. | |
BR9605153B1 (pt) | vacina de combinação, e, kit de vacinação. | |
IS4615A (is) | Mótefnavakar Helicobacter pylori og bóluefnablöndur | |
ES2093778T3 (es) | Nuevos anticuerpos y metodos para su uso. | |
BG99441A (en) | Oral application of antigens | |
AR010031A1 (es) | Vacuna oral para animales | |
NZ230148A (en) | Ibd (infectious bursal disease) monoclonal antibody vaccines, immunised chicks and a method of assaying for ibd | |
HK1005541A1 (en) | Treatment of helicobacter associated gastroduodenal disease | |
NZ502144A (en) | Multi-subtype FIV vaccines | |
DE69527986T2 (de) | Antigene arznei zur behandlung oder vorbeugung | |
DE69836976D1 (de) | Neospora impstoff | |
AR016396A1 (es) | Homogeneizado preparado a partir de celulas de neospora, vacuna, procedimiento para prepararlo, equipo de vacunacion y anticuerpo. | |
AU4277996A (en) | Presentation of hydrophobic antigens to t-cells by cd1 molecules | |
PT744027E (pt) | Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos | |
DE68914252T2 (de) | Verfahren zur Bestimmung eines Antigens. | |
PT636030E (pt) | Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1 | |
NO883603L (no) | Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel. | |
ATE206138T1 (de) | Helicobacter pylori antigen | |
BR0001559A (pt) | Vacina para a prevenção da colonização de campylobacter em animais, proteìna antigênica de campylobacter, uso de uma proteìna antigênica, vacina para a prevenção da colonização de campylobacter jejuni em galináceos, uso de anticorpos contra uma cepa de campylobacter sem flagelos, ou contra a proteìna antigênica, e, processo para a preparação de uma vacina | |
ES2169153T3 (es) | Anticuerpos opsonicos ampliamente reactivos que reaccionan con antigenos estafilococicos comunes. | |
NZ330913A (en) | Antigens for preventing and reducing parasite infection and disease | |
ATE369875T1 (de) | Orale vakzinierung mit nackten tumor-antigen- mimotopen | |
ITMI940891A0 (it) | Dispositivo di conservazione e di trasporto di organi umani sostanze medicinali vaccini e simili |